Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-01

AUTHORS

Hakuei Yamashita, Hiroo Yoda, Noriomi Kuroki, Michiko Kuwabara, Yuji Odagaki, Tetsushi Kazawa, Ryoichi Toyoshima, Taeko Maruki

ABSTRACT

RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance. OBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ. METHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (μU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR > 1.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed. RESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study. CONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance. More... »

PAGES

1-9

References to SciGraph publications

  • 2003-11. Relationship between levels of insulin or triglycerides and serum concentrations of the atypical antipsychotics clozapine and olanzapine in patients on treatment with therapeutic doses in PSYCHOPHARMACOLOGY
  • 1997-09. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • 2005. Comparison of the Effects of Valsartan and Felodipine on Plasma Leptin and Insulin Sensitivity in Hypertensive Obese Patients in HYPERTENSION RESEARCH
  • 1985-07. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man in DIABETOLOGIA
  • 2009-01. The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension in HYPERTENSION RESEARCH
  • 2010-06. Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis in NEUROPSYCHOPHARMACOLOGY
  • 2009-02. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients in HYPERTENSION RESEARCH
  • 1999-09. Olanzapine in CLINICAL PHARMACOKINETICS
  • 2008-04. Microalbuminuria Reduction with Telmisartan in Normotensive and Hypertensive Japanese Patients with Type 2 Diabetes: A Post-Hoc Analysis of the Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study in HYPERTENSION RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9

    DOI

    http://dx.doi.org/10.1007/s00213-010-2002-9

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1048620444

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/20820759


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin II Type 1 Receptor Blockers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antipsychotic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzimidazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzoates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzodiazepines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hyperinsulinism", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin Resistance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Olanzapine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptor, Angiotensin, Type 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Schizophrenia", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Telmisartan", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tetrazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Valine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Valsartan", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamashita", 
            "givenName": "Hakuei", 
            "id": "sg:person.01372434234.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372434234.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yoda", 
            "givenName": "Hiroo", 
            "id": "sg:person.0601220174.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601220174.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "National Center of Neurology and Psychiatry", 
              "id": "https://www.grid.ac/institutes/grid.419280.6", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan", 
                "Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kuroki", 
            "givenName": "Noriomi", 
            "id": "sg:person.01033241245.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033241245.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kuwabara", 
            "givenName": "Michiko", 
            "id": "sg:person.0765726277.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765726277.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Odagaki", 
            "givenName": "Yuji", 
            "id": "sg:person.01017742563.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017742563.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kazawa", 
            "givenName": "Tetsushi", 
            "id": "sg:person.012046357121.83", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012046357121.83"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Saitama Medical University", 
              "id": "https://www.grid.ac/institutes/grid.410802.f", 
              "name": [
                "Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Toyoshima", 
            "givenName": "Ryoichi", 
            "id": "sg:person.01066055763.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066055763.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maruki", 
            "givenName": "Taeko", 
            "id": "sg:person.0647333374.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647333374.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1056/nejmoa1001121", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001214885"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.diabres.2003.11.024", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005751248"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/hr.2008.31", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009767304", 
              "https://doi.org/10.1038/hr.2008.31"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012616091"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1097/hjh.0b013e3281fc975a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012616091"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1291/hypres.28.209", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013625707", 
              "https://doi.org/10.1291/hypres.28.209"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/hr.2008.18", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015339541", 
              "https://doi.org/10.1038/hr.2008.18"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1074/jbc.m103241200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016692557"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(09)60619-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018122882"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.cir.0000024416.33113.0a", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018363188"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-003-1529-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018877776", 
              "https://doi.org/10.1007/s00213-003-1529-4"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archpsyc.62.1.19", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020046671"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.metabol.2006.04.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021574484"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1592/phco.22.11.841.33629", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021839201"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.diabres.2004.11.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025133185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000203000103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025373687"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000203000103", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025373687"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(08)61764-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026964433"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00280883", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027902786", 
              "https://doi.org/10.1007/bf00280883"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.pnpbp.2007.08.022", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028964604"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1291/hypres.31.657", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029252385", 
              "https://doi.org/10.1291/hypres.31.657"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.cir.0000127955.36250.65", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029448060"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1017/s1092852900026663", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031913866"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmcp0909392", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032081491"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.clinbiochem.2007.05.009", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032335098"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033847339", 
              "https://doi.org/10.1038/npp.2010.21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.21", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033847339", 
              "https://doi.org/10.1038/npp.2010.21"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(04)16451-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034317205"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/oxfordjournals.epirev.a017978", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035014475"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003088-199937030-00001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035394480", 
              "https://doi.org/10.2165/00003088-199937030-00001"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.atv.11.1.80", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036167222"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0140-6736(07)60669-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037202954"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archpsyc.59.4.337", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1039319227"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.hyp.0000125142.41703.64", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040225085"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1161/01.hyp.0000125142.41703.64", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040225085"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.metabol.2006.04.013", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045685675"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa051688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047149354"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa051688", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047149354"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.euroneuro.2006.09.005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047595046"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/00498250500158175", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048048010"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000002800401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049009789"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/147323000002800401", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049009789"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/archinte.161.11.1413", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051518645"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.eurpsy.2005.05.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052612314"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002280050317", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053532490", 
              "https://doi.org/10.1007/s002280050317"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1176/appi.ajp.160.2.284", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1063495101"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diab.37.12.1595", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070735404"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diabetes.37.12.1595", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070741229"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.2337/diacare.22.9.1462", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1070748909"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4088/jcp.v62n0204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072207842"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.4088/jcp.v67n0408", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1072209452"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1074525287", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1077201408", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/central/cn-00563258", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1077201408"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://app.dimensions.ai/details/publication/pub.1078839834", 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1093/oxfordjournals.aje.a116768", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1082754453"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-01", 
        "datePublishedReg": "2011-01-01", 
        "description": "RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance.\nOBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ.\nMETHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (\u03bcU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR\u2009>\u20091.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed.\nRESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study.\nCONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1007/s00213-010-2002-9", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1085440", 
            "issn": [
              "0033-3158", 
              "1432-2072"
            ], 
            "name": "Psychopharmacology", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "213"
          }
        ], 
        "name": "Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine", 
        "pagination": "1-9", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "e79e72e369ebe8f66e5a5e0fcc8efe8e21d25dfa979c8412def8905cd8d4d6ae"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "20820759"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "7608025"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00213-010-2002-9"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1048620444"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00213-010-2002-9", 
          "https://app.dimensions.ai/details/publication/pub.1048620444"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T10:55", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000351_0000000351/records_43264_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://link.springer.com/10.1007%2Fs00213-010-2002-9"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00213-010-2002-9'


     

    This table displays all metadata directly associated to this object as RDF triples.

    355 TRIPLES      21 PREDICATES      97 URIs      39 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00213-010-2002-9 schema:about N0b1febb6f37c4cd3897f8a3a64586c06
    2 N0e04c27c47b7487181acd53d897069b7
    3 N1befde9ce98140ffaaeb4f625238fe94
    4 N2725b44c98074add90612c352d874627
    5 N39fa98f5cdc54c07abfd67bd3ec100d7
    6 N6c760aa0997941ff9536f46eb036070f
    7 N7e0ac3ec8d8b459fb7b73622b215b85b
    8 N82f4d6cdeb03453ab12754bc2534f350
    9 N8a337d312ea047b1b1b1354be70e53e4
    10 N8f6478a3d41d497199db46f763af376e
    11 Na2a6f27dc3ce46eea9ca56f14caedc6f
    12 Nbfc90016fe12473ba98db61b789d173a
    13 Ncd11afc5beb040f091a6330f273bee25
    14 Ne2b20b5cb03b46259c1494edcbdd50f2
    15 Nf13a240e3607402ca8c36a5b475140ba
    16 Nf25329a0a7bb4ee4abf2878538e565b1
    17 Nf8935c524b2a4726b9ba3e4f3ffb82c8
    18 Nfcf3c9b1a48b4da3bc98984057f4a3e2
    19 anzsrc-for:11
    20 anzsrc-for:1103
    21 schema:author Naa3af4ade287499bae2e84dae60627de
    22 schema:citation sg:pub.10.1007/bf00280883
    23 sg:pub.10.1007/s00213-003-1529-4
    24 sg:pub.10.1007/s002280050317
    25 sg:pub.10.1038/hr.2008.18
    26 sg:pub.10.1038/hr.2008.31
    27 sg:pub.10.1038/npp.2010.21
    28 sg:pub.10.1291/hypres.28.209
    29 sg:pub.10.1291/hypres.31.657
    30 sg:pub.10.2165/00003088-199937030-00001
    31 https://app.dimensions.ai/details/publication/pub.1074525287
    32 https://app.dimensions.ai/details/publication/pub.1077201408
    33 https://app.dimensions.ai/details/publication/pub.1078839834
    34 https://doi.org/10.1001/archinte.161.11.1413
    35 https://doi.org/10.1001/archpsyc.59.4.337
    36 https://doi.org/10.1001/archpsyc.62.1.19
    37 https://doi.org/10.1002/central/cn-00563258
    38 https://doi.org/10.1016/j.clinbiochem.2007.05.009
    39 https://doi.org/10.1016/j.diabres.2003.11.024
    40 https://doi.org/10.1016/j.diabres.2004.11.001
    41 https://doi.org/10.1016/j.euroneuro.2006.09.005
    42 https://doi.org/10.1016/j.eurpsy.2005.05.011
    43 https://doi.org/10.1016/j.metabol.2006.04.011
    44 https://doi.org/10.1016/j.metabol.2006.04.013
    45 https://doi.org/10.1016/j.pnpbp.2007.08.022
    46 https://doi.org/10.1016/s0140-6736(04)16451-9
    47 https://doi.org/10.1016/s0140-6736(07)60669-2
    48 https://doi.org/10.1016/s0140-6736(08)61764-x
    49 https://doi.org/10.1016/s0140-6736(09)60619-x
    50 https://doi.org/10.1017/s1092852900026663
    51 https://doi.org/10.1056/nejmcp0909392
    52 https://doi.org/10.1056/nejmoa051688
    53 https://doi.org/10.1056/nejmoa1001121
    54 https://doi.org/10.1074/jbc.m103241200
    55 https://doi.org/10.1080/00498250500158175
    56 https://doi.org/10.1093/oxfordjournals.aje.a116768
    57 https://doi.org/10.1093/oxfordjournals.epirev.a017978
    58 https://doi.org/10.1097/hjh.0b013e3281fc975a
    59 https://doi.org/10.1161/01.atv.11.1.80
    60 https://doi.org/10.1161/01.cir.0000024416.33113.0a
    61 https://doi.org/10.1161/01.cir.0000127955.36250.65
    62 https://doi.org/10.1161/01.hyp.0000125142.41703.64
    63 https://doi.org/10.1176/appi.ajp.160.2.284
    64 https://doi.org/10.1177/147323000002800401
    65 https://doi.org/10.1177/147323000203000103
    66 https://doi.org/10.1592/phco.22.11.841.33629
    67 https://doi.org/10.2337/diab.37.12.1595
    68 https://doi.org/10.2337/diabetes.37.12.1595
    69 https://doi.org/10.2337/diacare.22.9.1462
    70 https://doi.org/10.4088/jcp.v62n0204
    71 https://doi.org/10.4088/jcp.v67n0408
    72 schema:datePublished 2011-01
    73 schema:datePublishedReg 2011-01-01
    74 schema:description RATIONALE: Olanzapine (OLZ) is known to cause weight gain and metabolic disturbances, which may have serious implications with respect to medical comorbidities such as metabolic syndrome and insulin resistance. OBJECTIVES: The aim of this study was to evaluate the effects of two angiotensin II type 1 receptor blockers (ARBs) which are widely used as antihypertensive agents, valsartan (VAL) and telmisartan (TEL), on insulin resistance in patients with schizophrenia treated with OLZ. METHODS: Thirty inpatients with schizophrenia with OLZ monotherapy over 8 weeks participated in this study. To assess insulin resistance, the homeostasis model assessment of insulin resistance (HOMA-IR), fasting plasma glucose (PG) levels and immunoreactive insulin (IRI) levels were measured [HOMA-IR = fasting PG level (mmol/L) x fasting IRI level (μU/ml)/22.5]. VAL add-on treatment was performed in insulin-resistant patients (HOMA-IR > 1.6) for 12 weeks. After a 12-week VAL washout period, TEL add-on treatment was carried out for 12 weeks. The effects of ARBs on insulin resistance and other metabolic variables were assessed. RESULTS: In all 30 patients, both body mass index and abdominal circumference were strongly correlated with HOMA-IR. Twelve patients showed high HOMA-IR and were deemed to be insulin resistant. Add-on therapy of VAL and TEL resulted in a significant decrease in fasting IRI levels and HOMA-IR. No differences in any effects were observed between VAL and TEL. No adverse effects of either ARBs were observed in this study. CONCLUSIONS: ARBs for patients treated with OLZ improved insulin sensitivity and attenuated insulin resistance.
    75 schema:genre research_article
    76 schema:inLanguage en
    77 schema:isAccessibleForFree false
    78 schema:isPartOf N8fbe6621fcdf4013b42a6027c15db967
    79 Ndf74d2a6350d43c3b562f52095724a81
    80 sg:journal.1085440
    81 schema:name Angiotensin II type 1 receptor blockers improve insulin sensitivity in patients with schizophrenia being treated with olanzapine
    82 schema:pagination 1-9
    83 schema:productId N17a47c1350ff4c07a5b0515afe2d9e09
    84 Nbb7f32180ac347138efa92667ab5d823
    85 Nc24e745364c74181a94aa9a203f28d49
    86 Nfae811e424c64616823cdd75d3c35154
    87 Nfb10aae00ddc4a3ab80a6d0857ef90fb
    88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048620444
    89 https://doi.org/10.1007/s00213-010-2002-9
    90 schema:sdDatePublished 2019-04-11T10:55
    91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    92 schema:sdPublisher Nb8267310e8be463e804a1b5ebb9d5da5
    93 schema:url http://link.springer.com/10.1007%2Fs00213-010-2002-9
    94 sgo:license sg:explorer/license/
    95 sgo:sdDataset articles
    96 rdf:type schema:ScholarlyArticle
    97 N0b1febb6f37c4cd3897f8a3a64586c06 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    98 schema:name Male
    99 rdf:type schema:DefinedTerm
    100 N0e04c27c47b7487181acd53d897069b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    101 schema:name Tetrazoles
    102 rdf:type schema:DefinedTerm
    103 N17a47c1350ff4c07a5b0515afe2d9e09 schema:name readcube_id
    104 schema:value e79e72e369ebe8f66e5a5e0fcc8efe8e21d25dfa979c8412def8905cd8d4d6ae
    105 rdf:type schema:PropertyValue
    106 N1befde9ce98140ffaaeb4f625238fe94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    107 schema:name Middle Aged
    108 rdf:type schema:DefinedTerm
    109 N2461271696ec4ce29bf23db949aef0d2 rdf:first sg:person.012046357121.83
    110 rdf:rest Nbc8311597cd345ccb2b8a288abc22c64
    111 N2725b44c98074add90612c352d874627 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Olanzapine
    113 rdf:type schema:DefinedTerm
    114 N39fa98f5cdc54c07abfd67bd3ec100d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Valine
    116 rdf:type schema:DefinedTerm
    117 N43970d656c5f4781b3d06a0e9cb7c892 rdf:first sg:person.01033241245.91
    118 rdf:rest N9de90d222872461faf25cf3d226beb77
    119 N5b874d132a5c47469d1eb2bbeed045e6 rdf:first sg:person.0647333374.52
    120 rdf:rest rdf:nil
    121 N6c760aa0997941ff9536f46eb036070f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Valsartan
    123 rdf:type schema:DefinedTerm
    124 N7516aa663c9647b3966e65eeef1050cb schema:name Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    125 rdf:type schema:Organization
    126 N7dcca615baca40b8a6638650619c474c rdf:first sg:person.01017742563.44
    127 rdf:rest N2461271696ec4ce29bf23db949aef0d2
    128 N7e0ac3ec8d8b459fb7b73622b215b85b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Hyperinsulinism
    130 rdf:type schema:DefinedTerm
    131 N82f4d6cdeb03453ab12754bc2534f350 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Benzoates
    133 rdf:type schema:DefinedTerm
    134 N8a337d312ea047b1b1b1354be70e53e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Receptor, Angiotensin, Type 1
    136 rdf:type schema:DefinedTerm
    137 N8f6478a3d41d497199db46f763af376e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Benzodiazepines
    139 rdf:type schema:DefinedTerm
    140 N8fbe6621fcdf4013b42a6027c15db967 schema:volumeNumber 213
    141 rdf:type schema:PublicationVolume
    142 N9de90d222872461faf25cf3d226beb77 rdf:first sg:person.0765726277.27
    143 rdf:rest N7dcca615baca40b8a6638650619c474c
    144 Na2a6f27dc3ce46eea9ca56f14caedc6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    145 schema:name Schizophrenia
    146 rdf:type schema:DefinedTerm
    147 Na6eb3f1d771c4ade8104133880155e66 schema:name Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    148 rdf:type schema:Organization
    149 Naa3af4ade287499bae2e84dae60627de rdf:first sg:person.01372434234.34
    150 rdf:rest Nbc58d5452e9b482ebbc51e2b194c4581
    151 Nb8267310e8be463e804a1b5ebb9d5da5 schema:name Springer Nature - SN SciGraph project
    152 rdf:type schema:Organization
    153 Nbb7f32180ac347138efa92667ab5d823 schema:name dimensions_id
    154 schema:value pub.1048620444
    155 rdf:type schema:PropertyValue
    156 Nbc58d5452e9b482ebbc51e2b194c4581 rdf:first sg:person.0601220174.42
    157 rdf:rest N43970d656c5f4781b3d06a0e9cb7c892
    158 Nbc8311597cd345ccb2b8a288abc22c64 rdf:first sg:person.01066055763.17
    159 rdf:rest N5b874d132a5c47469d1eb2bbeed045e6
    160 Nbfc90016fe12473ba98db61b789d173a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Telmisartan
    162 rdf:type schema:DefinedTerm
    163 Nc24e745364c74181a94aa9a203f28d49 schema:name pubmed_id
    164 schema:value 20820759
    165 rdf:type schema:PropertyValue
    166 Ncd11afc5beb040f091a6330f273bee25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Angiotensin II Type 1 Receptor Blockers
    168 rdf:type schema:DefinedTerm
    169 Ndf74d2a6350d43c3b562f52095724a81 schema:issueNumber 1
    170 rdf:type schema:PublicationIssue
    171 Ne2b20b5cb03b46259c1494edcbdd50f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Humans
    173 rdf:type schema:DefinedTerm
    174 Nf13a240e3607402ca8c36a5b475140ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Insulin Resistance
    176 rdf:type schema:DefinedTerm
    177 Nf25329a0a7bb4ee4abf2878538e565b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    178 schema:name Female
    179 rdf:type schema:DefinedTerm
    180 Nf8935c524b2a4726b9ba3e4f3ffb82c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Antipsychotic Agents
    182 rdf:type schema:DefinedTerm
    183 Nfae811e424c64616823cdd75d3c35154 schema:name nlm_unique_id
    184 schema:value 7608025
    185 rdf:type schema:PropertyValue
    186 Nfb10aae00ddc4a3ab80a6d0857ef90fb schema:name doi
    187 schema:value 10.1007/s00213-010-2002-9
    188 rdf:type schema:PropertyValue
    189 Nfcf3c9b1a48b4da3bc98984057f4a3e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Benzimidazoles
    191 rdf:type schema:DefinedTerm
    192 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    193 schema:name Medical and Health Sciences
    194 rdf:type schema:DefinedTerm
    195 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    196 schema:name Clinical Sciences
    197 rdf:type schema:DefinedTerm
    198 sg:journal.1085440 schema:issn 0033-3158
    199 1432-2072
    200 schema:name Psychopharmacology
    201 rdf:type schema:Periodical
    202 sg:person.01017742563.44 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    203 schema:familyName Odagaki
    204 schema:givenName Yuji
    205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01017742563.44
    206 rdf:type schema:Person
    207 sg:person.01033241245.91 schema:affiliation https://www.grid.ac/institutes/grid.419280.6
    208 schema:familyName Kuroki
    209 schema:givenName Noriomi
    210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01033241245.91
    211 rdf:type schema:Person
    212 sg:person.01066055763.17 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    213 schema:familyName Toyoshima
    214 schema:givenName Ryoichi
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066055763.17
    216 rdf:type schema:Person
    217 sg:person.012046357121.83 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    218 schema:familyName Kazawa
    219 schema:givenName Tetsushi
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012046357121.83
    221 rdf:type schema:Person
    222 sg:person.01372434234.34 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    223 schema:familyName Yamashita
    224 schema:givenName Hakuei
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372434234.34
    226 rdf:type schema:Person
    227 sg:person.0601220174.42 schema:affiliation https://www.grid.ac/institutes/grid.410802.f
    228 schema:familyName Yoda
    229 schema:givenName Hiroo
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601220174.42
    231 rdf:type schema:Person
    232 sg:person.0647333374.52 schema:affiliation Na6eb3f1d771c4ade8104133880155e66
    233 schema:familyName Maruki
    234 schema:givenName Taeko
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647333374.52
    236 rdf:type schema:Person
    237 sg:person.0765726277.27 schema:affiliation N7516aa663c9647b3966e65eeef1050cb
    238 schema:familyName Kuwabara
    239 schema:givenName Michiko
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765726277.27
    241 rdf:type schema:Person
    242 sg:pub.10.1007/bf00280883 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027902786
    243 https://doi.org/10.1007/bf00280883
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1007/s00213-003-1529-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018877776
    246 https://doi.org/10.1007/s00213-003-1529-4
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1007/s002280050317 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053532490
    249 https://doi.org/10.1007/s002280050317
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/hr.2008.18 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015339541
    252 https://doi.org/10.1038/hr.2008.18
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/hr.2008.31 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009767304
    255 https://doi.org/10.1038/hr.2008.31
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/npp.2010.21 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033847339
    258 https://doi.org/10.1038/npp.2010.21
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1291/hypres.28.209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013625707
    261 https://doi.org/10.1291/hypres.28.209
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1291/hypres.31.657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029252385
    264 https://doi.org/10.1291/hypres.31.657
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.2165/00003088-199937030-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035394480
    267 https://doi.org/10.2165/00003088-199937030-00001
    268 rdf:type schema:CreativeWork
    269 https://app.dimensions.ai/details/publication/pub.1074525287 schema:CreativeWork
    270 https://app.dimensions.ai/details/publication/pub.1077201408 schema:CreativeWork
    271 https://app.dimensions.ai/details/publication/pub.1078839834 schema:CreativeWork
    272 https://doi.org/10.1001/archinte.161.11.1413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051518645
    273 rdf:type schema:CreativeWork
    274 https://doi.org/10.1001/archpsyc.59.4.337 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039319227
    275 rdf:type schema:CreativeWork
    276 https://doi.org/10.1001/archpsyc.62.1.19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020046671
    277 rdf:type schema:CreativeWork
    278 https://doi.org/10.1002/central/cn-00563258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077201408
    279 rdf:type schema:CreativeWork
    280 https://doi.org/10.1016/j.clinbiochem.2007.05.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032335098
    281 rdf:type schema:CreativeWork
    282 https://doi.org/10.1016/j.diabres.2003.11.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005751248
    283 rdf:type schema:CreativeWork
    284 https://doi.org/10.1016/j.diabres.2004.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025133185
    285 rdf:type schema:CreativeWork
    286 https://doi.org/10.1016/j.euroneuro.2006.09.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047595046
    287 rdf:type schema:CreativeWork
    288 https://doi.org/10.1016/j.eurpsy.2005.05.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052612314
    289 rdf:type schema:CreativeWork
    290 https://doi.org/10.1016/j.metabol.2006.04.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021574484
    291 rdf:type schema:CreativeWork
    292 https://doi.org/10.1016/j.metabol.2006.04.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045685675
    293 rdf:type schema:CreativeWork
    294 https://doi.org/10.1016/j.pnpbp.2007.08.022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028964604
    295 rdf:type schema:CreativeWork
    296 https://doi.org/10.1016/s0140-6736(04)16451-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034317205
    297 rdf:type schema:CreativeWork
    298 https://doi.org/10.1016/s0140-6736(07)60669-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037202954
    299 rdf:type schema:CreativeWork
    300 https://doi.org/10.1016/s0140-6736(08)61764-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1026964433
    301 rdf:type schema:CreativeWork
    302 https://doi.org/10.1016/s0140-6736(09)60619-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1018122882
    303 rdf:type schema:CreativeWork
    304 https://doi.org/10.1017/s1092852900026663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031913866
    305 rdf:type schema:CreativeWork
    306 https://doi.org/10.1056/nejmcp0909392 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032081491
    307 rdf:type schema:CreativeWork
    308 https://doi.org/10.1056/nejmoa051688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047149354
    309 rdf:type schema:CreativeWork
    310 https://doi.org/10.1056/nejmoa1001121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001214885
    311 rdf:type schema:CreativeWork
    312 https://doi.org/10.1074/jbc.m103241200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016692557
    313 rdf:type schema:CreativeWork
    314 https://doi.org/10.1080/00498250500158175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048048010
    315 rdf:type schema:CreativeWork
    316 https://doi.org/10.1093/oxfordjournals.aje.a116768 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082754453
    317 rdf:type schema:CreativeWork
    318 https://doi.org/10.1093/oxfordjournals.epirev.a017978 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035014475
    319 rdf:type schema:CreativeWork
    320 https://doi.org/10.1097/hjh.0b013e3281fc975a schema:sameAs https://app.dimensions.ai/details/publication/pub.1012616091
    321 rdf:type schema:CreativeWork
    322 https://doi.org/10.1161/01.atv.11.1.80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036167222
    323 rdf:type schema:CreativeWork
    324 https://doi.org/10.1161/01.cir.0000024416.33113.0a schema:sameAs https://app.dimensions.ai/details/publication/pub.1018363188
    325 rdf:type schema:CreativeWork
    326 https://doi.org/10.1161/01.cir.0000127955.36250.65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029448060
    327 rdf:type schema:CreativeWork
    328 https://doi.org/10.1161/01.hyp.0000125142.41703.64 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040225085
    329 rdf:type schema:CreativeWork
    330 https://doi.org/10.1176/appi.ajp.160.2.284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063495101
    331 rdf:type schema:CreativeWork
    332 https://doi.org/10.1177/147323000002800401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049009789
    333 rdf:type schema:CreativeWork
    334 https://doi.org/10.1177/147323000203000103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025373687
    335 rdf:type schema:CreativeWork
    336 https://doi.org/10.1592/phco.22.11.841.33629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021839201
    337 rdf:type schema:CreativeWork
    338 https://doi.org/10.2337/diab.37.12.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070735404
    339 rdf:type schema:CreativeWork
    340 https://doi.org/10.2337/diabetes.37.12.1595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070741229
    341 rdf:type schema:CreativeWork
    342 https://doi.org/10.2337/diacare.22.9.1462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070748909
    343 rdf:type schema:CreativeWork
    344 https://doi.org/10.4088/jcp.v62n0204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072207842
    345 rdf:type schema:CreativeWork
    346 https://doi.org/10.4088/jcp.v67n0408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072209452
    347 rdf:type schema:CreativeWork
    348 https://www.grid.ac/institutes/grid.410802.f schema:alternateName Saitama Medical University
    349 schema:name Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    350 Department of Psychiatry, Moro Hospital, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    351 rdf:type schema:Organization
    352 https://www.grid.ac/institutes/grid.419280.6 schema:alternateName National Center of Neurology and Psychiatry
    353 schema:name Department of Neuropsychiatry, Faculty of Medicine, Saitama Medical University, 38 Morohongo, Moroyama, Iruma-gun, Saitama, Japan
    354 Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan
    355 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...